+ Follow STROKE MONITORY SYSTEM Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 194372
[Title] => First treatment for acute ischaemic stroke launched
[Summary] => INGELHEIM, Germany Boehringer Ingelheim has announced the European launch of Actilyse (altiplase) as the first and only treatment for acute ischaemic stroke after being approved by the European Commission.
The EC approved the use of the Actilyse treatment of selected patients with acute ischaemic stroke in the 0-3 hour window, based on the results of international clinical trials.
[DatePublished] => 2003-02-06 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
STROKE MONITORY SYSTEM
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 194372
[Title] => First treatment for acute ischaemic stroke launched
[Summary] => INGELHEIM, Germany Boehringer Ingelheim has announced the European launch of Actilyse (altiplase) as the first and only treatment for acute ischaemic stroke after being approved by the European Commission.
The EC approved the use of the Actilyse treatment of selected patients with acute ischaemic stroke in the 0-3 hour window, based on the results of international clinical trials.
[DatePublished] => 2003-02-06 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
abtest
February 6, 2003 - 12:00am